Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Cai Lay Veterinary Pharmaceutical

Market Cap: ₫48.5b

Manufactures and supplies veterinary pharmaceutical products in Vietnam and Indochina.

Ascletis Pharma

Market Cap: HK$10.3b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

Antengene

Market Cap: HK$4.0b

A clinical-stage APAC biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.

ReproCELL

Market Cap: JP¥19.0b

Provides stem cell research and drug discovery services in Japan.

Winston Medical Supply

Market Cap: NT$2.1b

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

Guangdong Zhongsheng Pharmaceutical

Market Cap: CN¥14.4b

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Highnoon Laboratories

Market Cap: PK₨61.0b

Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.

Humanwell Healthcare (Group)Ltd

Market Cap: CN¥34.4b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

Shanghai Kaibao PharmaceuticalLtd

Market Cap: CN¥6.3b

Engages in the research, development, production, and sale of modern Chinese medicines primarily in China.

Boryung

Market Cap: ₩711.3b

Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.

Sichuan Kelun Pharmaceutical

Market Cap: CN¥58.7b

Researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China.

Kukje Pharma

Market Cap: ₩89.2b

Engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products.

Biotron

Market Cap: AU$4.0m

A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.

WDB coco

Market Cap: JP¥6.5b

Provides contract services to pharmaceutical companies in Japan.

Cleo Diagnostics

Market Cap: AU$48.8m

A biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia.

Abbisko Cayman

Market Cap: HK$11.4b

Engages in the research and development of pharmaceutical products in the People’s Republic of China and the European Union.

Anavex Life Sciences

Market Cap: US$730.1m

Operates as a biopharmaceutical company.

MBX Biosciences

Market Cap: US$774.7m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Silo Pharma

Market Cap: US$7.0m

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company.

BioArctic

Market Cap: SEK 25.3b

Develops biological drugs for patients with central nervous system disorders in Sweden.

SciSparc

Market Cap: US$3.3m

A clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.

Lexeo Therapeutics

Market Cap: US$351.0m

A clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.

Sonoma Pharmaceuticals

Market Cap: US$6.7m

Develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.

LAVA Therapeutics

Market Cap: US$41.8m

Operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments.

Cocrystal Pharma

Market Cap: US$16.3m

A biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.

ALK-Abelló

Market Cap: DKK 44.7b

Operates as an allergy solutions company in Europe, North America, and internationally.

BioInvent International

Market Cap: SEK 1.9b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Basilea Pharmaceutica

Market Cap: CHF 555.4m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Entero Therapeutics

Market Cap: US$7.5m

A clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.

Invex Therapeutics

Market Cap: AU$12.0m

A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.

Denali Therapeutics

Market Cap: US$2.0b

A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.

PMV Pharmaceuticals

Market Cap: US$74.2m

A precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.

Vir Biotechnology

Market Cap: US$719.6m

A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.

ECO Animal Health Group

Market Cap: UK£66.7m

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.

ESSA Pharma

Market Cap: US$9.5m

A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

Molecular Partners

Market Cap: CHF 104.5m

A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.